Checkpoint Capital L.P. Top Holdings and 13F Report (2025) About Checkpoint Capital L.P.Investment ActivityCheckpoint Capital L.P. has $182.27 million in total holdings as of March 31, 2025.Checkpoint Capital L.P. owns shares of 14 different stocks, but just 5 companies or ETFs make up 80% of its holdings.Approximately 32.11% of the portfolio was purchased this quarter.About 32.83% of the portfolio was sold this quarter.This quarter, Checkpoint Capital L.P. has purchased 16 new stocks and bought additional shares in 8 stocks.Checkpoint Capital L.P. sold shares of 1 stock and completely divested from 7 stocks this quarter.Largest Holdings argenx $68,064,475Rhythm Pharmaceuticals $48,056,503Revolution Medicines $13,861,509Soleno Therapeutics $12,353,848Disc Medicine $12,077,958 Largest New Holdings this Quarter 74366E102 - Protagonist Therapeutics $8,471,898 Holding81734D104 - SEPTERNA INC $4,776,044 Holding218352102 - Corcept Therapeutics $571,100 Holding45258D105 - Immunocore $267,356 Holding75382E109 - RAPT Therapeutics $133,993 Holding Largest Purchases this Quarter argenx 22,500 shares (about $13.32M)Rhythm Pharmaceuticals 179,258 shares (about $9.50M)Protagonist Therapeutics 175,184 shares (about $8.47M)Soleno Therapeutics 102,875 shares (about $7.35M)Revolution Medicines 182,011 shares (about $6.44M) Largest Sales this Quarter CIDARA THERAPEUTICS INC 92,569 shares (about $1.99M) Sector Allocation Over TimeMap of 500 Largest Holdings ofCheckpoint Capital L.P. Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorARGXargenx$68,064,475$13,316,963 ▲24.3%115,00037.3%MedicalRYTMRhythm Pharmaceuticals$48,056,503$9,495,296 ▲24.6%907,24026.4%MedicalRVMDRevolution Medicines$13,861,509$6,435,909 ▲86.7%392,0117.6%MedicalSLNOSoleno Therapeutics$12,353,848$7,350,419 ▲146.9%172,9026.8%MedicalIRONDisc Medicine$12,077,958$2,894,558 ▲31.5%243,3116.6%MedicalPTGXProtagonist Therapeutics$8,471,898$8,471,898 ▲New Holding175,1844.6%MedicalSTOKStoke Therapeutics$4,859,268$2,828,444 ▲139.3%730,7172.7%MedicalSEPTERNA INC$4,776,044$4,776,044 ▲New Holding824,8782.6%COMKYMRKymera Therapeutics$3,738,879$1,616,746 ▲76.2%136,6052.1%MedicalTCRXTScan Therapeutics$2,784,357$361,095 ▲14.9%2,017,6501.5%MedicalCIDARA THERAPEUTICS INC$2,248,345$1,993,936 ▼-47.0%104,3801.2%COM NEWCORTCorcept Therapeutics$571,100$571,100 ▲New Holding5,0000.3%MedicalIMCRImmunocore$267,356$267,356 ▲New Holding9,0110.1%MedicalRAPTRAPT Therapeutics$133,993$133,993 ▲New Holding109,8300.1%MedicalPHATPhathom Pharmaceuticals$0$18,466,155 ▼-100.0%00.0%MedicalAXSMAxsome Therapeutics$0$14,787,205 ▼-100.0%00.0%MedicalAVADEL PHARMACEUTICALS PLC$0$10,560,343 ▼-100.0%00.0%COM SHSPLRXPliant Therapeutics$0$7,052,456 ▼-100.0%00.0%MedicalTRVITrevi Therapeutics$0$4,466,636 ▼-100.0%00.0%MedicalLIFEaTyr Pharma$0$1,565,871 ▼-100.0%00.0%MedicalCYTKCytokinetics$0$940,800 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
